Kaluzny AD - Search Results

1

Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.

Klabunde CN, Kaluzny AD. Klabunde CN, et al. Among authors: kaluzny ad. Breast Cancer Res Treat. 1995 Jul;35(1):43-50. doi: 10.1007/BF00694744. Breast Cancer Res Treat. 1995. PMID: 7612903 Clinical Trial.

2

Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual.

Klabunde C, Kaluzny A, Ford L. Klabunde C, et al. Cancer Epidemiol Biomarkers Prev. 1995 Oct-Nov;4(7):783-9. Cancer Epidemiol Biomarkers Prev. 1995. PMID: 8672997

3

Physicians' reactions to change in recommendations for mammography screening.

Klabunde CN, O'Malley MS, Kaluzny AD. Klabunde CN, et al. Among authors: kaluzny ad. Am J Prev Med. 1997 Nov-Dec;13(6):432-8. Am J Prev Med. 1997. PMID: 9415788

4

Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.

Kaluzny AD, Lacey LM, Warnecke R, Hynes DM, Morrissey J, Ford L, Sondik E. Kaluzny AD, et al. Health Serv Res. 1993 Jun;28(2):159-82. Health Serv Res. 1993. PMID: 8514498 Free PMC article.

5

Performance in quasi-firms: an example from the Community Clinical Oncology Program.

Lacey LM, Hynes DM, Kaluzny AD. Lacey LM, et al. Among authors: kaluzny ad. J Health Hum Resour Adm. 1992 Winter;14(3):307-26. J Health Hum Resour Adm. 1992. PMID: 10118501

6

Accrual of patients to randomized clinical trials. Factors affecting cancer prevention and control research.

Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik EJ, Ford L. Kaluzny AD, et al. Int J Technol Assess Health Care. 1994 Summer;10(3):506-16. doi: 10.1017/s0266462300006723. Int J Technol Assess Health Care. 1994. PMID: 8071011

7

Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.

Kaluzny A, Brawley O, Garson-Angert D, Shaw J, Godley P, Warnecke R, Ford L. Kaluzny A, et al. J Natl Cancer Inst. 1993 Dec 1;85(23):1945-50. doi: 10.1093/jnci/85.23.1945. J Natl Cancer Inst. 1993. PMID: 8230286

8

Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program.

Kaluzny AD, Ricketts T 3rd, Warnecke R, Ford L, Morrissey J, Gillings D, Sondik EJ, Ozer H, Goldman J. Kaluzny AD, et al. J Natl Cancer Inst. 1989 Nov 15;81(22):1717-25. doi: 10.1093/jnci/81.22.1717. J Natl Cancer Inst. 1989. PMID: 2681795 Clinical Trial.

9

Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities.

Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik E, Ford L. Kaluzny AD, et al. Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):261-9. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8019377

10

Cancer prevention and control within the National Cancer Institute's clinical trials network: lessons from the Community Clinical Oncology Program.

Kaluzny AD, Warnecke RB, Lacey LM, Morrissey JP, Gillings D, Ozer H. Kaluzny AD, et al. J Natl Cancer Inst. 1993 Nov 17;85(22):1807-11. doi: 10.1093/jnci/85.22.1807. J Natl Cancer Inst. 1993. PMID: 8230260 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters